Anti-Influenza A Virus Nucleoprotein 抗体 [9G8] (ab43821)
Key features and details
- Mouse monoclonal [9G8] to Influenza A Virus Nucleoprotein
- Suitable for: ELISA, WB, ICC/IF
- Reacts with: Influenza A
- Isotype: IgG2a
製品の概要
-
製品名
Anti-Influenza A Virus Nucleoprotein antibody [9G8]
Influenza A Virus Nucleoprotein 一次抗体 製品一覧 -
製品の詳細
Mouse monoclonal [9G8] to Influenza A Virus Nucleoprotein -
由来種
Mouse -
アプリケーション
適用あり: ELISA, WB, ICC/IFmore details -
種交差性
交差種: Influenza A -
免疫原
Recombinant full length protein corresponding to Influenza A Virus Nucleoprotein.
-
特記事項
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
バッファー
Constituents: 0.75% Glycine, 1.21% Tris, 2% Sucrose -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
9G8 -
アイソタイプ
IgG2a -
軽鎖の種類
kappa -
研究分野
関連製品
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab43821の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
ELISA |
1/2000 - 1/10000.
|
|
WB |
1/200 - 1/1000.
|
|
ICC/IF |
1/100 - 1/500.
On infected cells |
特記事項 |
---|
ELISA
1/2000 - 1/10000. |
WB
1/200 - 1/1000. |
ICC/IF
1/100 - 1/500. On infected cells |
ターゲット情報
-
関連性
The nucleoprotein (NP) of Influenza virus encapsulates the negative strand of the viral RNA and is essential for replicative transcription. It may also be involved in other essential functions throughout the virus life cycle. As well as binding ssRNA, NP is able to self associate to form large oligomeric complexes. NP is able to interact with a variety of other macromolecules of both viral and cellular origins. It binds the PB1 and PB2 subunits of the polymerase and the matrix protein M1. "NP has also been shown to interact with at least four cellular polypeptide families: nuclear import receptors of the importin class, filamentous (F) actin, the nuclear export receptor CRM1 and a DEAD box helicase BAT1/UAP56" (Portela et al 2002). -
細胞内局在
Host cell nucleus -
参照データベース
- Entrez Gene: 956531 Influenza A
- SwissProt: P03466 Influenza A
- SwissProt: P69291 Influenza A
-
別名
- Common flu NP antibody
- Influenza A virus NP antibody
- NP antibody
see all
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (7)
ab43821 は 7 報の論文で使用されています。
- Dorna J et al. Effects of Receptor Specificity and Conformational Stability of Influenza A Virus Hemagglutinin on Infection and Activation of Different Cell Types in Human PBMCs. Front Immunol 13:827760 (2022). PubMed: 35359920
- Ganti K et al. Rab11a mediates cell-cell spread and reassortment of influenza A virus genomes via tunneling nanotubes. PLoS Pathog 17:e1009321 (2021). PubMed: 34473799
- Harbig A et al. Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways. J Biol Chem 295:11388-11407 (2020). PubMed: 32303635
- Phipps KL et al. Collective interactions augment influenza A virus replication in a host-dependent manner. Nat Microbiol 5:1158-1169 (2020). PubMed: 32632248
- Seo YJ et al. Sphingosine kinase 1 serves as a pro-viral factor by regulating viral RNA synthesis and nuclear export of viral ribonucleoprotein complex upon influenza virus infection. PLoS One 8:e75005 (2013). WB . PubMed: 24137500
- Dimmock NJ et al. Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir. Antiviral Res 96:376-85 (2012). PubMed: 23041142
- Killingley B et al. Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings. Health Technol Assess 14:237-354 (2010). PubMed: 20923613